Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Aug;53(8):1117-22.
doi: 10.1136/gut.2003.030734.

Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease

D G Forcione  1 , M J Rosen, J B Kisiel, B E Sands
Affiliations

Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease

D G Forcione et al. Gut. 2004 Aug.

Abstract

Background: Anti-Saccharomyces cerevisiae antibodies (ASCA) are a specific but only moderately sensitive diagnostic marker for Crohn's disease. We sought to explore the role of ASCA as a prognostic marker for aggressive disease phenotype in Crohn's disease.

Aims: To determine the role of ASCA status as a risk factor for early surgery in Crohn's disease.

Subjects: We performed a case control study in a cohort of patients, newly diagnosed with Crohn's disease, between 1991 and 1999. All patients were followed for at least three years. Case subjects (n = 35) included those who had major surgery for Crohn's disease within three years of diagnosis. Controls (n = 35) included patients matched to cases for age, sex, disease location, and smoking status, and who did not undergo major surgery for Crohn's disease within three years of diagnosis.

Methods: Blinded assays were performed on serum for ASCA (immunoglobulin (Ig)A and IgG). A paired analysis of cases-controls was performed to test for the association between ASCA status and risk of early surgery.

Results: ASCA IgA was strongly associated with early surgery (odds ratio (OR) 8.5 (95% confidence interval (CI) 2.0-75.9); p = 0.0013). ASCA IgG+ and ASCA IgG+/IgA+ patients were also at increased risk for early surgery (OR 5.5 (95% CI 1.2-51.1), p = 0.0265; and OR 5.0 (95% CI 1.1-46.9), p = 0.0433, respectively). The association between ASCA and early surgery was evident in patients requiring surgery for ileal or ileocolonic disease.

Conclusions: Patients with Crohn's disease who are positive for ASCA IgA, IgG, or both, may define a subset of patients with Crohn's disease at increased risk for early surgery.

PubMed Disclaimer

References

    1. Hananuer SB, Sandborn WJ. Management of Crohn’s disease in adults. Am J Gastroenterol 2001;96:635–43. - PubMed
    1. Mekhjian HS, Switz DM, Melnyk CS, et al. Clinical features and natural history of Crohn’s disease. Gastroenterology 1979;77:898–906. - PubMed
    1. Binder V , Hendriksen C, Kreiner S. Prognosis in Crohn’s disease-based on results from a regional patient group from the county of Copenhagen. Gut 1985;26:146–50. - PMC - PubMed
    1. Elliott PR, Ritchie JK, Lennard-Jones JE. Prognosis of colonic Crohn’s disease. Br Med J (Clin Res Ed) 1985;291:178. - PMC - PubMed
    1. Basilisco G , Campanini M, Cesana B, et al. Risk factors for first operation in Crohn’s disease. Am J Gastroenterol 1989;84:749–52. - PubMed

Publication types

MeSH terms